Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
Longevity Prediction Market

Which disease area will Anthropic disclose first?

approved openMultiple choicePrognosis made 1 Jul 2026Voting closes 1 Nov 20260 traders0.00 cr volume

Chance it happens

80%
Happens 80%No 10%Other 10%

Belief the predicted event happens at all — every “yes / by-a-date” outcome added together. “Other” is tracked as its own third slice.

Outcomes

Neglected or infectious disease10.0%
Aging or longevity10.0%
Oncology10.0%
Rare genetic disease10.0%
Immunology / autoimmune10.0%
Allergology / allergy10.0%
Neurology / neurodegeneration10.0%
Cardiovascular / metabolic10.0%
Won't disclose by close10.0%
Other area10.0%

Resolution criteria

The first disease area Anthropic publicly names for an internal program. Resolution horizon: 2027-12-31. Source: Anthropic.

Evidence & context

Trials, publications and reports our research found on this prognosis. Each links to the original source.

Anthropic

This appears to be a news item stating that Anthropic launched an internal drug discovery program targeting neglected diseases. If genuine, it directly bears on the prediction because it names a disease area for Anthropic's internal program.

Belief over time — chance it happens

0255075100Jul 1 · 80.0% chance80.0% chance
Jul 1Jul 1

Recent trades

No trades yet.